Speaker illustration

Doctor Irina Savelieva

St George's University of London, London (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Heart Rythm Association

Dr Savelieva MD, PhD (Cardiology), PhD (Electrophysiology), FESC, FEHRA, is Clinical Lecturer in Cardiology at St George’s University of London. Her main interests are electrophysiology, cardiac arrhythmias, and all aspects of atrial fibrillation. She is a principal investigator in several large-scale clinical trials in AF and serves on faculty boards of cardiology and specialist arrhythmia societies including ESC, EHRA, HRS, HRC-UK, AHA, ACC, Cardiostim, WAS, ICPES, and ISCP. She served on the ESC Task Force for Guidelines on management of atrial fibrillation in 2010, focused update in 2012, and as a document reviewer for the ESC Guidelines in 2016. She is a member of the EHRA Documents Writing Committee after joining in 2012, AF Science Evolution Working Group, Joint EHRA/AFNET Working Group, and AF-SCREEN International Collaboration Consensus Working Group on AF. She is Deputy Editor for EP-Europace having served since 2007 and Associate Editor for Clinical Cardiology.

Debates in atrial fibrillation ablation (2)

Event: EHRA 2024

Topic: Atrial Fibrillation (AF)

Session type: Debate Session

Thumbnail

Atrial fibrillation: stroke - oral anticoagulants

Event: EHRA 2024

Topic: Atrial Fibrillation (AF)

Session type: Abstract Sessions

Thumbnail

Atrial fibrillation: beyond stroke prevention and rhythm control

Event: ESC Congress 2023

Topic: Atrial Fibrillation (AF)

Session type: Abstract Sessions

Thumbnail

What does the future hold for factor XIa vs. factor Xa inhibitors in atrial fibrillation, acute coronary syndrome and stroke?

Event: ESC Congress 2023

Topic: Cardiovascular Pharmacotherapy

Session type: Symposium

Thumbnail

Stroke and bleeding risk in atrial fibrillation: walking the tight rope

Event: ESC Congress 2023

Topic: Atrial Fibrillation (AF)

Session type: Advances in Science

Thumbnail

Remodelling, prognosis, and outcomes in atrial fibrillation

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session type: Moderated ePosters

Thumbnail

Prognosis and outcome in patients with atrial fibrillation

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session type: Moderated ePosters

Thumbnail

Atrial Fibrillation - Round 2 - Stroke, ACO

Event: EHRA 2023

Topic: Atrial Fibrillation (AF)

Session type: Abstract Sessions

Thumbnail

Insights on prognosis and outcome of common arrhythmia disorders

Event: ESC Congress 2022

Topic: Pathophysiology and Mechanisms

Session type: Moderated ePosters

Thumbnail

Great Debate: device-detected subclinical AF should be treated like clinical AF. All patients with HF and AF should undergo AF ablation

Event: ESC Congress 2022

Topic: Stroke Treatment

Session type: Great Debates

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb